What is Apostrophe?
Apostrophe operates as a specialized healthcare savings platform designed to streamline the complex financial interactions between self-insured employers, medical providers, and plan members. As a certified B Corporation and Techstars graduate, the company distinguishes itself through a commitment to radical transparency and operational simplicity. Its core value proposition centers on reducing healthcare expenditures by an average of 20% or more during the initial year of implementation. By integrating concierge-level support with a curated suite of digital health solutions, Apostrophe effectively rewires the traditional benefits model, ensuring that healthcare coverage remains both accessible and economically sustainable for modern enterprises.
How much funding has Apostrophe raised?
Apostrophe has raised a total of $5.6M across 2 funding rounds:
Angel/Seed
$5.3M
Debt
$350K
Angel/Seed (2018): $5.3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in Apostrophe
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the early-stage funding round to support the initial development of the healthcare savings platform.
What's next for Apostrophe?
With the infusion of this latest capital, Apostrophe is well-positioned to scale its enterprise-level operations and expand its market footprint. The strategic focus will likely shift toward enhancing its digital infrastructure and deepening its penetration within the self-insured employer market. As the company navigates its current lifecycle stage, the emphasis remains on maintaining its high-touch service model while leveraging data-driven insights to further reduce administrative friction. Future growth will be defined by the firm's ability to maintain its B-Corp standards while scaling its proprietary technology to meet the evolving needs of large-scale health benefit programs.
See full Apostrophe company page
